← Leaderboards
Saad J. Kenderian
Mayo Clinic Rochester
$4,264,786
Attributed
$4,502,286
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$4,502,286 · 2
By mechanism
R37$2,917,317 · 1
R01$1,584,969 · 1
Top collaborators
- Wesley Wierson1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Evanthia Galanis$13,573,895
- Kah-Whye Peng$11,311,466
- Jamie N Bakkum-Gamez$820,154
- Jorg J Goronzy$24,125,737
- Gregory A Worrell$20,841,105
Others in their field
Other Rising Stars on “Prevent”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Melissa Basford · Vanderbilt University Medical Center$37,410,924
- David Annett · Information Management Services, Inc.$34,721,865
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Lee Lichtenstein · Vanderbilt University Medical Center$26,108,724
- Dorota A. Grejner-Brzezinska · University Of Wisconsin-Madison$19,883,568
Research focus
PreventT-LymphocyteClinical TrialsChimeric Antigen ReceptorSiteNovel StrategiesIn VivoCell TherapyCytokineCellsPre-Clinical ModelPreventionPathway InteractionsKnock-OutS LymphomaIn VitroReceptorPre-ClinicalCancer TherapyNeurotoxicityB Lymphoid MalignancyCar T Cell TherapyCytokine Release SyndromeLarge Cell Diffuse Non-Hodgkin&Apos
Grant awards (7)
Engineered Mesenchymal Stromal Cells for Enhanced Immunosuppression$807,447
R01 · FY2025 · AI · contact PI
Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines$616,157
R37 · FY2025 · CA · contact PI
Engineered Mesenchymal Stromal Cells for Enhanced Immunosuppression$777,522
R01 · FY2024 · AI · contact PI
Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines$600,395
R37 · FY2024 · CA · contact PI
Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines$619,433
R37 · FY2023 · CA · contact PI
Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines$475,000
R37 · FY2023 · CA · contact PI
Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines$606,332
R37 · FY2022 · CA · contact PI